FirstFT: the day's biggest stories
Latest research based on animal model trials shows GLP-1 drugs may prevent problem of ‘no-reflow’ in recovery
FDA Commissioner Marty Makary announced last week that the federal agency will begin offering performance-based cash bonuses to staff who complete drug reviews ahead of schedule. The pilot program, dubbed the “Reviewer Recognition and Excellence” program, involved “some wrangling” by the commissioner, who apparently told FDA staffers as much, according to the Associated Press.，推荐阅读51吃瓜获取更多信息
+export USE_CCACHE=1。业内人士推荐币安_币安注册_币安下载作为进阶阅读
Бритни Спирс арестовали20:54，推荐阅读搜狗输入法获取更多信息
Nature, Published online: 04 March 2026; doi:10.1038/s41586-025-10045-7